Restore   Mind Medicine slide image

Restore Mind Medicine

Delayed Clinical Development Pipeline All of MindMed's clinical trials have faced significant delays. Goal Initiation of MM-120 GAD Phase llb Initiation of MM-120 ADHD Phase lla Completion of MM-110 Phase I Touted Date September of 2021 End of 2020 April of 2021 Actual Date Source: Company SEC Filings, Company SEDAR Filings, MindMed Press Releases, Clinical trials.gov August of 2022 December 17, 2021 December 31, 2021 Shareholders have no basis to believe management's representations about the progress of its clinical programs. 26
View entire presentation